Holen Sie sich die Stockscreener-App
16.46
2.68%
0.43
Handel nachbörslich:
16.46
Schlusskurs vom Vortag:
$16.03
Offen:
$16.07
24-Stunden-Volumen:
3.83M
Relative Volume:
1.12
Marktkapitalisierung:
$3.93B
Einnahmen:
$474.17M
Nettoeinkommen (Verlust:
$208.93M
KGV:
19.38
EPS:
0.8493
Netto-Cashflow:
$65.61M
1W Leistung:
+7.09%
1M Leistung:
+13.20%
6M Leistung:
-19.51%
1J Leistung:
-24.43%
1-Tages-Spanne:
$15.93
$16.67
1-Wochen-Bereich:
$13.76
$16.67
52-Wochen-Spanne:
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Firmenname
Adma Biologics Inc
Sektor
Branche
Telefon
(201) 478-5552
Adresse
C/O ADMA BIOLOGICS, INC., RAMSEY
Vergleichen Sie ADMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
16.46 | 3.50B | 474.17M | 208.93M | 65.61M | 0.8493 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.19 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.72 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.74 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.89 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
377.47 | 36.43B | 4.56B | -176.77M | 225.30M | -1.7177 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-19 | Fortgesetzt | Raymond James | Strong Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-11-11 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-04 | Eingeleitet | Jefferies | Buy |
| 2019-04-15 | Bestätigt | H.C. Wainwright | Buy |
| 2019-02-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-12-11 | Bestätigt | Maxim Group | Buy |
| 2017-11-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2016-08-01 | Herabstufung | Maxim Group | Buy → Hold |
| 2016-07-25 | Bestätigt | Maxim Group | Buy |
| 2015-05-13 | Bestätigt | Maxim Group | Buy |
| 2014-12-08 | Eingeleitet | Oppenheimer | Outperform |
| 2014-12-01 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Adma Biologics Inc Aktie (ADMA) Neueste Nachrichten
Adma Biologics (ADMA) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance
Adma Biologics (ADMA) Crossed Above the 50-Day Moving Average: What That Means for Investors - Yahoo Finance
Why ADMA Biologics' (NASDAQ:ADMA) Earnings Are Weaker Than They Seem - Yahoo Finance
Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 108.5%: Here's is How to Trade - sharewise.com
Can ADMA Biologics Inc. stock attract ESG capital inflows2025 Volume Leaders & Reliable Entry Point Alerts - newser.com
(ADMA) Volatility Zones as Tactical Triggers - news.stocktradersdaily.com
Adma Biologics Shares Maintain Upward Momentum on Strong Financial Performance - AD HOC NEWS
Is ADMA Biologics Inc a good long term investmentEmerging Market Stocks & Capital Planning and Optimization - earlytimes.in
ADMA Biologics (ADMA) Is Down 8.1% After Raising Revenue Guidance Through 2029 Has The Bull Case Changed? - Yahoo Finance
ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2025 Earnings Call Transcript - Insider Monkey
Will ADMA Biologics Inc. stock continue dividend increasesBuy Signal & Expert Approved Trade Ideas - newser.com
ADMA Biologics Inc earnings matched, revenue topped estimates By Investing.com - Investing.com Australia
ADMA Biologics Inc. Reports Strong Q3 Earnings Call - TipRanks
ADMA's Q3 Earnings Match Estimates, Revenues Beat on Strong Asceniv Sales - sharewise.com
ADMA Biologics (ADMA) Reports Record Revenue Growth in Q3 2025 - GuruFocus
ADMA Biologics Reports Strong Q3 2025 Financial Results - The Globe and Mail
Adma Biologics: Q3 Earnings Snapshot - CT Insider
ADMA Biologics Ups Guidance After Outpacing Revenue Estimates - Finimize
Risk adjusted return profile for ADMA Biologics Inc. analyzed2025 Support & Resistance & Verified Chart Pattern Trade Signals - newser.com
Decoding ADMA Biologics Inc (ADMA): A Strategic SWOT Insight - GuruFocus
ADMA Biologics Inc (ADMA) Q3 2025 Earnings Call Highlights: Reco - GuruFocus
ADMA Biologics Inc (ADMA) Q3 2025 Earnings Call Highlights: Record Growth and Strategic Advancements - Yahoo Finance
ADMA Raises Financial Projections, Boosts FY26 EBITDA Forecast - GuruFocus
Adma Biologics (ADMA) Q3 Earnings Match Estimates - sharewise.com
ADMA Biologics Announces Third Quarter 2025 Financial Results and Provides Business Update - The Globe and Mail
Earnings call transcript: ADMA Biologics Q3 2025 sees steady revenue growth - Investing.com Nigeria
ADMA Biologics Inc earnings matched, revenue topped estimates - Investing.com
Biopharmaceutical firm ADMA's Q3 revenue beats estimates - MarketScreener
ADMA Outlines Strategic Vision for Earnings Growth and Value Cre - GuruFocus
ADMA BIOLOGICS, INC. SEC 10-Q Report - TradingView
ADMA Q3 Revenue Surpasses Expectations, Signals Strong Future Gr - GuruFocus
ADMA Biologics (ADMA) Q3 Revenue Surpasses Expectations - GuruFocus
ADMA Biologics Inc Surpasses Q3 2025 Expectations with EPS of $0 - GuruFocus
Earnings Flash (ADMA) ADMA Biologics, Inc. Reports Q3 Revenue $134.2M, vs. FactSet Est of $130.5M - MarketScreener
108,400 Shares in ADMA Biologics Inc $ADMA Acquired by Homestead Advisers Corp - MarketBeat
Hussman Strategic Advisors Inc. Sells 42,000 Shares of ADMA Biologics Inc $ADMA - MarketBeat
Applying Wyckoff theory to ADMA Biologics Inc. stockJuly 2025 Intraday Action & Long-Term Investment Growth Plans - newser.com
ADMA Biologics Inc (ADMA) Q3 2025: Everything You Need to Know A - GuruFocus
ADMA Biologics Inc (ADMA) Q3 2025: Everything You Need to Know Ahead of Earnings - Yahoo Finance
Will ADMA Biologics Inc. stock keep outperforming rivalsDollar Strength & Stepwise Entry and Exit Trade Signals - newser.com
Y Intercept Hong Kong Ltd Buys 38,809 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc expected to post earnings of 15 cents a shareEarnings Preview - TradingView
ADMA Biologics (ADMA): Evaluating Valuation After Major Institutional Exit by Palisades Investment Partners - Yahoo Finance
Building trade automation scripts for ADMA Biologics Inc.Market Movers & Verified Technical Signals - newser.com
Finanzdaten der Adma Biologics Inc-Aktie (ADMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Adma Biologics Inc-Aktie (ADMA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Grossman Adam S | President and CEO |
Oct 24 '25 |
Sale |
16.00 |
21,000 |
336,000 |
2,019,850 |
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):